Mildly elevated liver transaminase levels in the asymptomatic patient

American Family Physician

Volumn 71, Issue 6, 2005, Pages 1105-1110

  Giboney, Paul T ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; FLUCONAZOLE; GLIBENCLAMIDE; HEPARIN; HERBACEOUS AGENT; ISONIAZID; KETOCONAZOLE; LABETALOL; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYTOIN; PROTEINASE INHIBITOR; SULFONAMIDE; TRAZODONE;

ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; DIABETES MELLITUS; DISEASE MARKER; ECHOGRAPHY; ENZYME CHEMISTRY; FAMILY HISTORY; HEART DISEASE; HUMAN; LIFESTYLE; LIVER BIOPSY; LIVER CIRRHOSIS; OBESITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SEROLOGY; STEATOSIS; THYROID DISEASE; VIRUS HEPATITIS;

ALANINE TRANSAMINASE; ALGORITHMS; ASPARTATE AMINOTRANSFERASES; DECISION TREES; HUMANS; LIVER DISEASES;

EID: 15444376333     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367-84.
2. Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci 1993;38:2145-50.
3. Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. BMJ 2001;322:276-8.
4. American Gastroenterological Association. Medical position statement: evaluation of liver chemistry tests. Gastroenterology 2002;123:1364-6.
5. Davern TJ, Scharschmidt BF. Biochemical liver tests. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders, 2002:1227-38.
6. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71.
7. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-22.
8. Bayraktar M, Van Thiel DH. Abnormalities in measures of liver function and injury in thyroid disorders. Hepatogastroenterology 1997;44:1614-8.
9. Bathum L, Petersen HC, Rosholm JU, Hyltoft Petersen P, Vaupel J, Christensen K. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem 2001;47:81-7.
10. Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees. J Clin Epidemiol 2001;54:945-51.
11. Kaur S, Rybicki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results from the National Hepatitis Screening Survey. Hepatology 1996;24:979-86.
12. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999;94:3010-4.
13. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
14. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis [published correction appears in Ann Intern Med 1997;127(8 pt 1):658]. Ann Intern Med 1997;126:137-45.